Boston Scientific Corporation Acquires Asthmatx for $443,500,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    888 Ross Drive Sunnyvale, CA 94089
  • Company Description
    Asthmatx, Inc. is focused on helping patients with asthma breathe easier. We are developing an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with moderate to severe asthma. Multiple clinical studies are underway to evaluate the safety and efficacy of this device in potentially improving the lives of patients with asthma. One of these studies, the Air2Trial is presently enrolling patients.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The deal is worth $193.5 million in cash plus up to $250 million more based on revenue-based earnout.

Trending on Xconomy